[#item_full_content] Two hemp companies have sued the U.S. Drug Enforcement Administration over a new rule that classifies a hemp-derived cannabinoid known as HHC as a Schedule I controlled substance, setting up what could become one of the most significant legal battles yet over the future of hemp-derived products. According to petitions first reported on by Law360, Read More